Securities Code: 301367 Securities Abbreviation: Ruimait Announcement Number: 2026-049 Beijing Ruimait Medical Technology Co., Ltd. Announcement on the Progress of Repurchasing Company Shares to Reach 1%
The Company and the entire Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.
Beijing Ruimait Medical Technology Co., Ltd. (hereinafter referred to as the "Company") held its third board of directors' twentieth meeting on April 27, 2026, and its 2025 annual shareholders' meeting on May 15, 2026. Both meetings deliberated and approved the "Proposal on the Company's Share Repurchase Plan." It was agreed that the Company would use its concentrated surplus funds to repurchase issued RMB common shares (A shares) through centralized bidding transactions, with an amount of no less than RMB 60 million and no more than RMB 120 million (inclusive). The repurchased shares will be used for employee stock ownership plans or equity incentives. The repurchase price will not exceed RMB 103.96 per share (inclusive). The implementation period for the share repurchase will not exceed 12 months from the date the repurchase plan is approved by the Company's shareholders' meeting.